BSX - Boston Scientific Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BSX is currently covered by 27 analysts with an average price target of $114.68. This is a potential upside of $12.78 (12.54%) from yesterday's end of day stock price of $101.9.

Boston Scientific Corp's activity chart (see below) currently has 315 price targets and 415 ratings on display. The stock rating distribution of BSX is 91.91% BUY and 8.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.5% with an average time for these price targets to be met of 305.15 days.

Highest price target for BSX is $130, Lowest price target is $78, average price target is $104.71.

Most recent stock forecast was given by MATT MIKSIC from BARCLAYS on 25-Apr-2025. First documented stock forecast 30-Jan-2013.

Currently out of the existing stock ratings of BSX, 159 are a BUY (91.91%), 14 are a HOLD (8.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$125

$23.1 (22.67%)

$118

2 days ago
(25-Apr-2025)

15/17 (88.24%)

$23.1 (22.67%)

316

Buy

$120

$18.1 (17.76%)

$91

3 days ago
(24-Apr-2025)

8/9 (88.89%)

$18.86 (18.65%)

140

Buy

$117

$15.1 (14.82%)

$113

3 days ago
(24-Apr-2025)

13/16 (81.25%)

$15.86 (15.68%)

151

Buy

$112

$10.1 (9.91%)

$90

3 days ago
(24-Apr-2025)

14/15 (93.33%)

$10.86 (10.74%)

84

Buy

$115

$13.1 (12.86%)

$113

3 days ago
(24-Apr-2025)

25/27 (92.59%)

$13.86 (13.70%)

279

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BSX (Boston Scientific Corp) average time for price targets to be met?

On average it took 305.15 days on average for the stock forecasts to be realized with a an average price target met ratio 94.5

Which analyst has the current highest performing score on BSX (Boston Scientific Corp) with a proven track record?

JOHN EADE

Which analyst has the most public recommendations on BSX (Boston Scientific Corp)?

John Eade works at ARGUS and has 6 price targets and 4 ratings on BSX

Which analyst is the currently most bullish on BSX (Boston Scientific Corp)?

Danielle Antalffy with highest potential upside - $28.1

Which analyst is the currently most reserved on BSX (Boston Scientific Corp)?

Tao Levy with lowest potential downside - -$80.25

Boston Scientific Corp in the News

GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform

GoodRx GDRX recently rolled out a new e-commerce experience aimed at improving how consumers obtain their prescriptions through its platform. This upgraded system offers a more streamlined and user-friendly way for individuals to compare prices, apply discounts, and order medications for pickup or delivery. The initial launch is in collaboration with Hy-Vee, a prominent Midwest-based...

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Insulet Corporation PODD recently made its Omnipod 5 Automated Insulin Delivery (“AID”) system commercially available in Canada for people with type 1 diabetes (ages two years and above). Omnipod 5 is available with Dexcom G6 and G7 continuous glucose monitoring (“CGM”) sensor compatibility. The latest development represents a significant step forward in expanding access to...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?